- Home
- TSE vs FENC Comparison
TSE vs FENC Comparison
Compare TSE & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSE
- FENC
- Stock Information
- Founded
- TSE 2010
- FENC 1996
- Country
- TSE United States
- FENC United States
- Employees
- TSE N/A
- FENC N/A
- Industry
- TSE Major Chemicals
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TSE Industrials
- FENC Health Care
- Exchange
- TSE Nasdaq
- FENC Nasdaq
- Market Cap
- TSE 157.3M
- FENC 181.7M
- IPO Year
- TSE 2014
- FENC 2001
- Fundamental
- Price
- TSE $3.57
- FENC $4.39
- Analyst Decision
- TSE
- FENC Strong Buy
- Analyst Count
- TSE 0
- FENC 2
- Target Price
- TSE N/A
- FENC $14.00
- AVG Volume (30 Days)
- TSE 347.1K
- FENC 98.6K
- Earning Date
- TSE 11-06-2024
- FENC 11-07-2024
- Dividend Yield
- TSE 1.13%
- FENC N/A
- EPS Growth
- TSE N/A
- FENC N/A
- EPS
- TSE N/A
- FENC N/A
- Revenue
- TSE $3,529,200,000.00
- FENC $49,348,000.00
- Revenue This Year
- TSE N/A
- FENC $116.50
- Revenue Next Year
- TSE $4.87
- FENC $17.49
- P/E Ratio
- TSE N/A
- FENC N/A
- Revenue Growth
- TSE N/A
- FENC 278.09
- 52 Week Low
- TSE $1.94
- FENC $3.99
- 52 Week High
- TSE $8.83
- FENC $11.92
- Technical
- Relative Strength Index (RSI)
- TSE 31.98
- FENC 48.64
- Support Level
- TSE $3.53
- FENC $3.99
- Resistance Level
- TSE $3.75
- FENC $4.57
- Average True Range (ATR)
- TSE 0.33
- FENC 0.29
- MACD
- TSE -0.13
- FENC 0.01
- Stochastic Oscillator
- TSE 17.32
- FENC 50.24
About TSE Trinseo PLC
Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include latex binders, feedstocks, polystyrene, Americas styrenics, engineered materials, and plastics solutions. Majority of the revenue is generated from its Polystyrene segment which provides a variety of general purpose polystyrenes, and high impact polystyrene. These products provide customers with performance and aesthetics at a relatively low cost across applications, including appliances, packaging, including food packaging and food service disposables, consumer electronics and building and construction materials. Geographically, the company generates majority of the revenue from Europe and also has its presence in United States, Asia-Pacific and other regions.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.